Emerging Markets Earnings Roundup: Bayer, Teva, Mylan (Part 7)
This article was originally published in PharmAsia News
Executive Summary
Bayer attributes record global sales in its 150-year history to emerging markets and new products such as Xarelto; Teva expands global footprint, and Mylan focuses on its injectables business in emerging markets.